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The purpose of this study was to assess the LEPR gene Gln223Arg polymorphism (rs1137101) in oral squamous cell
carcinoma (OSCC) and in potentially malignant oral lesions (PMOL) in comparison to normal oral mucosa in a
Brazilian population. Smokers (n = 89) were selected from a representative sample of 471 individuals from the
general population of Montes Claros, Brazil. Participants were age and gender matched to patients with OSCC
(n = 25) and oral epithelial dysplasia (n = 25). We investigated the LEPR Gln223Arg polymorphism (A>G; rs1137101)
in these groups. Genotype variants were assessed by RFLP-PCR, using MspI (HPAII) restriction endonuclease. The
institutional review board of the Universidade Estadual de Montes Claros approved the study (process number
2667/2011). Written informed consent for this study was obtained from all participants. The GG genotype
(Arg223Arg) appears to be the more relevant polymorphic variant in OSCC. It occurred, approximately, twice as
frequently in OSCC patients than in the general population. In contrast, the A allele in its homozygosis form
(Gln223Gln) is significantly associated with the development of PMOL; 80% of the samples from the PMOL group
exhibit AA genotype. Our findings suggest new insights regarding LEPR gene variations in the development of
OSCC and PMOL.
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Leptin (LEP) is a protein of the cytokine family, com-
prised of 167 amino acids. It is mainly synthesized in
adipose tissue and is related to energy metabolism and
body weight through hypothalamic regulation. Its func-
tion is achieved when it binds to its receptor, the Leptin
receptor protein (LEPR) (Ahima and Osei 2004). In
addition, the LEP gene has been linked to the other
physiologic and pathologic mechanisms, such as bone* Correspondence: jguveme@gmail.com; andreluizguimaraes@gmail.com
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development of some cancers (Ribeiro et al. 2004; Okobia
et al. 2008; Beccari et al. 2013). The activated signaling
pathway and proteins formed by LEP-LEPR linking has
been associated with cancer pathogenesis due to interac-
tions with Janus kinase tyrosine (JAK-2), suppressors of
cytokine signaling (SOCS), and the signal transducer and
activator of transcription-3 (STAT) (Fruhbeck et al. 1998;
Ahima and Osei 2004).
The identification of Leptin receptor antagonists cap-
able of blocking the effects of Leptin could lead to the
development of new therapeutic procedures for the
treatment of various types of cancer. One recently devel-
oped peptide was associated with the inhibition of sev-
eral Leptin-induced pathway in breast and colorectalis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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PI3K/AKT, cyclin D1, and E-cadherin (Beccari et al.
2013). Furthermore, polymorphisms in the LEP and
LEPR genes have been associated with several cancer
types, such as colon, prostate, and breast cancers
(Ribeiro et al. 2004; Okobia et al. 2008; Slattery et al.
2008). In prostate cancer, analysis of LEP polymorphism
rs7799039 demonstrated that the A allele was associated
with higher expression of the Leptin receptor (Ribeiro
et al. 2004). Leptin has also been reported to interfere
with the expression of oncogenic c-myc and anti-
apoptotic bcl-2, regulate cell turnover and facilitate the
progression of cervical cancer (Yuan et al. 2013).
The LEPR polymorphism Gln223Arg is characterized
by an A to G transition in codon 223, resulting in a glu-
tamine to arginine substitution (Chung et al. 1997).
Higher levels of Leptin binding activity were shown in
homozygous individuals for the G allele (Arg223Arg)
(Quinton et al. 2001). However, there were contrary results
of lower Leptin binding to the G allele in a study involving
postmenopausal White women (Stefan et al. 2002).
The LEPR 223Arg allele has been associated with in-
creased risk of breast cancer (Okobia et al. 2008). Simi-
larly, in hepatocellular carcinoma (HCC), the 223Arg/
Arg genotype had a significantly higher risk for HCC
than the 223Gln/Gln genotype (Li et al. 2012).
Few studies have been performed to explain the sig-
nificance of LEP and LEPR genes in oral malignances
(Yapijakis et al. 2009; Gharote and Mody 2010). Therefore,
in order to obtain better knowledge about the Leptin re-
ceptor gene in oral cancer, we evaluated polymorphic vari-
ants of LEPR Gln223Arg in the mucosa of patients with
OSCC and PMOL compared to normal oral mucosa.
Patients and methods
Study and design
We performed a case-control study to verify a possible
association between polymorphisms of the Leptin recep-
tor gene (GenBank: U59251 - Nucleotide Database of
National Center for Biotechnology Information, U.S.A)
and OSCC and/or PMOL. To test our hypothesis, we first
performed a study with a sample of non-institutionalized
adults from the city of Montes Claros, Minas Gerais,
Brazil. Montes Claros has approximately 361.915 inhabi-
tants and 95.1% of them live in the urban area. Sample size
calculation was performed to estimate the number of par-
ticipants need for a representative sample of the municipal
population (confidence level 95%, standard error <4% and
event prevalence 50.0%). From a representative sample of
724 individuals, we selected only smoking individuals
without OSCC or PMOL (n = 89), who were matched for
age, sex, and smoking habits with OSCC (n = 25) and oral
epithelial dysplasia patients (n = 25). Diagnosis of OSCC
and PMOL in participants was confirmed throughhistopathologic analysis. In this study, only oral epithelial
dysplasia was considered as PMOL. The study was ap-
proved by the institutional review board of the Universi-
dade Estadual de Montes Claros (process number 2667/
2011). Written informed consent for this study was ob-
tained from all participants.
Leptin receptor genotyping
DNA was extracted from oral mucosa scrapings from a
control group and from the lesions of participants diag-
nosed with OSCC or PMOL. DNA samples were isolated
using silica particles, which absorb the DNA. Subse-
quently, DNA was washed to remove impurities and was
eluted in TE buffer, as previously described (Guimaraes
et al. 2007). DNA from paraffin embedded tissue was ex-
tracted as previously described (Fraga et al. 2012; de
Carvalho Fraga et al. 2013).
Leptin receptor gene polymorphism Gln223Arg (A>G;
rs1137101) was assessed by RFLP-PCR. Polymerase chain
reaction for the LEPR gene was performed using 500 ng of
genomic DNA as a template. Other reagents were used,
including 4 μM of each of the following primers: F: 5′-A
CCCTTTAAGCTGGGTGTCCCAAATAG-3′; R: 5′CAAT
ATTTATGGGCTGAACTGACATT-3′; 330 bp), 0.1 mM
of each DNTP (Amersham Biosciences, Pittsburgh, PA,
USA), 1X PCR buffer, 2.5 mM magnesium chloride, and
2.5 U of Platinum Taq DNA polymerase (Invitrogen Life
Technologies, Carlsbad, CA, USA). The 330 bp PCR prod-
uct was digested with MspI (HPAII) restriction endonucle-
ase (Fermentas Life Sciences, Lithuania) that recognizes the
restriction site (C/CGG). For this SNP, the A allele lacks a
MspI restriction site. Thus, individuals carrying the A allele
show only one PCR band (330-bp), while carriers of the G
allele show two bands (293 and 37 bp) (Figure 1). 10 μl of
amplified DNA was digested with 1.0 U of MspI for 16 h at
37°C. PCR and restriction reactions were performed in a
thermocycler (Eppendorf AG, Hamburg, Germany). The
PCR products were visualized by electrophoresis in 10%
acrylamide gel stained with silver. Positive control for diges-
tion reaction was used.
Statistical analysis
The Chi-square test was used to compare genotypic distri-
butions of Leptin receptor gene polymorphism Gln223Arg
and clinical data in the studied groups. Statistical analyses
were carried out using SPSS 17.0 software. Probability
values <0.05 were considered statistically significant.
Results
Clinical data and group distributions are displayed in
Table 1. Histologic gradation of OSCC and PMOL was
not considered in this study. Lesions were only histo-
logically classified as OSCC and PMOL. Table 2 shows
the genotype distribution of the LEPR polymorphism
Figure 1 RFLP gel electrophoresis gel. “NS” means no sample was added.
Domingos et al. SpringerPlus 2014, 3:683 Page 3 of 5
http://www.springerplus.com/content/3/1/683by group. The A allele in its homozygosis state
(Gln223Gln) shows significant association with PMOL;
80% of the samples exhibit the AA genotype. On the
other hand, the GG genotype (Arg223Arg) appears to
be the more common polymorphic variant in OSCC. It
occurred, approximately, twice as frequently in OSCC
patients than in the control group. The control group
had higher frequencies of AG and AA variants. The
GG genotype showed lower distribution in these sam-
ples; the A allele seems to be more important in this
group. No association between gender and LEPR geno-
type variants were observed (Table 3). No associations
were observed among controls, PMOL, OSCC and
clinicopathological variables.
Discussion
Leptin (LEP) is a hormone secreted from adipocytes
that plays an important role in energetic metabolism,
control of food intake, and obesity through its binding
to LEPR receptors (Dutta et al. 2012). Leptin receptors
are mainly found in the hypothalamus. However, some
studies indicate that other tissues may produce this pro-
tein, such as skeletal muscle, liver, kidney, bone marrow,




General population/smokers PMOL OSCC
(n = 89) (n = 25) (n = 25)
Gender
Male 67 (75.3%) 17 (68.0%) 21 (84.0%)
Female 22 (24.7%) 08 (32.0%) 04 (16.0%)
Age (in years)
Variation 28-92 36-82 28-77
Mean ± SD 55.9 ± 13.9 58.1 ± 12.0 58.0 ± 13.62003). An isoform of the LEPR gene was also expressed
in oral keratinocytes (Groschl et al. 2005). It has been
suggested that there is an association between Leptin re-
ceptor Gln223Arg polymorphisms and increased risk for
oral cancer (Yapijakis et al. 2009; Gharote and Mody
2010). Related studies from out laboratory have found
associations between metabolic genetic markers and
OSCC (Correa et al. 2011; Fonseca-Silva et al. 2012;
Fraga et al. 2012), a fact that prompted us to investigate
whether there is a difference between frequencies of
variants of the Gln223Arg polymorphism between case
and control groups.
The LEPR Gln223Arg polymorphism, resulting in a
change of glutamine to arginine at codon 223 in exon 6
of Receptor Leptin gene, has been associated with the de-
velopment of and increased risk for cancer. In breast
cancer, for example, LEPR 223Arg was associated with
increased serum Leptin levels (Quinton et al. 2001).
However, studies are in conflict regarding which variant
of the LEPR Gln223Arg polymorphism is associated with
a higher risk of cancer. A meta-analysis study suggested
that the presence of the A allele (LEPR Gln223) is a risk
factor in breast cancer (Wang et al. 2012). However,
other similar research indicated that a higher frequencyTable 2 Frequency of LEPR genotypes in normal oral
mucosa, potentially malignant oral lesions, and oral
squamous cell carcinoma
LEPR genotype
Group GG (%) AG (%) AA (%)
General population/smokers 11 (12.4) 38 (42.7) 40 (44.9)
Potentially malignant oral lesion 01 (4.0) 04 (16.0) 20 (80.0)
OSCC 06 (24.0) 07 (28.0) 12 (48.0)
p-value 0.011*
*Analyzed by X2 test. Significant p-value < 0.05.
Table 3 LEPR genotypes associated with gender in normal oral mucosa, potentially malignant lesions, and oral
squamous cell carcinoma
General population/smokers Potentially malignant lesion OSCC
Variables GG (%) AG (%) AA (%) GG (%) AG (%) AA (%) GG (%) AG (%) AA (%)
Gender
Male 07 (63.6) 33 (86.8) 27 (67.5) 01 (100.0) 03 (75.0) 13 (65.0) 05 (83.3) 07 (100.0) 09 (75.0)
Female 04 (36.4) 05 (13.2) 13 (32.5) 0 (0.0) 01 (25.0) 07 (35.0) 01 (16.7) 0 (0.0) 03 (25.0)
p-value* 0.089 0.725 0.357
*Analyzed by X2 test. Significant p-value < 0.05.
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creased risk. Additionally, the risk of breast cancer asso-
ciated to the G allele differed based on ethnicity (Liu
and Liu 2011).
In this study, we hypothesized that variants of the
LEPR Gln223Arg polymorphism can be associated with
oral squamous cell carcinoma and PMOL. Despite the
small group of cases, our results were able to demon-
strate a significantly increased frequency of the GG
genotype (Arg223Arg) in cancer patients in comparison
to the control group. The GG genotype was twice as
common in the OSCC and PMOL group than in the
control group. A previous study showed that breast can-
cer patients with the G allele were more likely to de-
velop poorly differentiated tumors than those with the A
allele (Gu et al. 2012). However, it has been suggested
that the A allele (LEPR Gln223) is an important risk fac-
tor in breast cancer (Wang et al. 2012). The GG geno-
type of the LEPR Gln223Arg polymorphism was
significantly prevalent in non-small cell lung cancer (Li
et al. 2012). We found only one published study that
investigated the LEPR Gln223Arg polymorphism in
oral cancer (Yapijakis et al. 2009). Similar to our find-
ings, these investigators also found a higher frequency
of the GG genotype in subjects with oral cancer.
PMOL is a lesion with potential for becoming squa-
mous cell carcinoma (Napier and Speight 2008). Studies
have focused on the investigation of molecular, genetic,
and epigenetic alterations in these oral lesions, such as
p16 methylation (Fonseca-Silva et al. 2012), genetic poly-
morphisms (Fraga et al. 2012), microRNAs (Brito et al.
2013) and protein expression restricted to malignant
cells as MAGE-A (Ries et al. 2012). Analysis of LEP-
LEPR in PMOL was not previously investigated. There-
fore, we examined frequencies of the LEPR Gln223Arg
polymorphism in the mucosa of OSCC and PMOL pa-
tients and a control group without the disease. The A
allele in its homozygosis state (Gln223Gln) was signifi-
cantly associated with PMOL with 80% of the samples
exhibiting the AA genotype. This is the first report in-
vestigating the relationship between LEPR polymorph-
ism and OSCC and PMOL. Other studies are needed tounderstand the role of LEPR variants in the develop-
ment and progression of oral cancers, especially in rela-
tion to Leptin levels or in association with the stages of
dysplasia. It is important to highlight that considering
the complexity of gene expression control, it is not pos-
sible to know whether the results are influenced by
other environmental variables involved.
In conclusion, our findings suggest a need for further
investigation of the relationship between variants of the
LEPR gene and the development and progression of oral
cancer. LEP-LEPR signalling may be implicated in patho-
genesis of these lesions. Additional studies may lead to a
clearer understanding of the mechanism by which allelic
variation in the Gln223Arg gene affects risk for the de-
velopment and progression of oral cancer.
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